September 30, 2016 4:17 AM ET

Life Sciences Tools and Services

Company Overview of PsychoGenics Inc.

Company Overview

PsychoGenics Inc. provides preclinical contract research and drug discovery services. The company offers various in vivo tests in the areas of animal models, anxiety, cognition, depression and sexual function, drug abuse liability, epilepsy, injury and pain, micro-dialysis, motor function, neurogenesis, neurological disorders, schizophrenia and mania, and other areas; and in vitro and ex vivo tests in the areas of electrophysiology, neurochemistry, quantitative western blots and quantitative RT-PCR and ELISA, and receptor occupancy. It also creates a range of drug candidates to address various CNS disorders, such as ADHD, cognitive impairment, depression, psychiatric and neurodegenerative di...

765 Old Saw Mill River Road

Tarrytown, NY 10591

United States

Founded in 1999





Key Executives for PsychoGenics Inc.

Chief Executive Officer and President
Co-Founder and Director
Co-Founder and Director
Co-Founder, Chairman of the Scientific Advisory Board and Principal Scientific Advisor
Senior Vice President of Behavioral Pharmacology
Compensation as of Fiscal Year 2016.

PsychoGenics Inc. Key Developments

PGI Drug Discovery LLC Announces Drug Discovery Collaboration with Sunovion Pharmaceuticals Inc

PGI Drug Discovery LLC announced that a compound identified through its drug discovery collaboration with Sunovion Pharmaceuticals Inc. has achieved a milestone. The compound, SEP-856, is a potential antipsychotic agent with a novel mechanism of action being investigated as a possible treatment for patients with schizophrenia. The preclinical models for SEP-856 suggest that it may have the potential to treat the negative symptoms of schizophrenia.

PsychoGenics Inc. Presents at 1st Annual Neuroscience BioPartnering & Investment Forum, Feb-23-2016

PsychoGenics Inc. Presents at 1st Annual Neuroscience BioPartnering & Investment Forum, Feb-23-2016. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY 10007, United States. Presentation Date & Speakers: Feb-23-2016, Emer Leahy, Chief Executive Officer and President.

PsychoGenics Extends its Drug Discovery Collaboration with Sunovion

PGI Drug Discovery LLC (PsychoGenics) announced that the Company has extended its drug discovery and development collaboration with Sunovion Pharmaceuticals Inc. (Sunovion) for another four years. In August 2007, PsychoGenics and Sunovion entered into a drug discovery and development agreement to combine their complementary strengths and expertise to screen compound libraries and identify a new generation of treatments for neuropsychiatric disorders. Since then the companies have expanded the scope of the collaboration, which has led to the identification of potential drug candidates including a compound in clinical development.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PsychoGenics Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at